Dana-Farber Cancer Institute, United States
Disclosure information not submitted.
Poster T2 - Exploiting therapy response dynamics to overcome fibroblast-mediated drug resistance in HER2+ breast cancer
Thursday, October 24, 20242:45 PM – 3:45 PM EST